<DOC>
	<DOCNO>NCT00791128</DOCNO>
	<brief_summary>The purpose study determine whether GI Sleeve safe effective treat Type II diabetes patient</brief_summary>
	<brief_title>Study Pre-Surgical Weight Loss Type II Diabetes Patients</brief_title>
	<detailed_description>Patients obesity significantly great risk develop complication pulmonary dysfunction , diabetes , hypertension , co-morbid risk . NIH panel recommendation state even 10 % short-weight loss would greatly reduce risk . GI Dynamics ' GI Sleeve represent viable alternative short-term pre-surgical weight loss method . GI Sleeve device implant remove minimal invasive endoscopic technique . This endoscopic procedure bring potential benefit patient minimally invasive , efficacious , allow patient recover fast less morbidity mortality .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<criteria>Age 18 65 BMI 40 60 Type II Diabetes Candidates bariatric surgery Patients hepatitis B C GERD HIV Positive diagnosis pancreatitis condition gastrointestinal tract , ulcer Crohn 's infection H. Pylori positive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Type 2 Diabetes</keyword>
</DOC>